Increase in adoption of personalized medicine for the screening and diagnostics of genetic disorders, and rise in disposable income in emerging economies
Increase in adoption of personalized medicine for the screening and diagnostics of genetic disorders, and rise in disposable income in emerging economies
Rise in adoption of personalized medicine for the screening and diagnostics of genetic disorders and technological advancements in single-cell analysis products drive the growth of the global single cell multi-omics market. The market across North America held the largest share in 2020, accounting for nearly half of the market. However, the rise in chronic diseases and infectious diseases such as Covid-19 increased the demand for single cell multi-omics.
Global Single Cell Multi-omics Market was pegged at $2.45 billion in 2020, and is expected to reach $13.90 billion by 2030, growing at a CAGR of 19.0% from 2021 to 2030.
Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/12148
Covid-19 scenario:
- The Covid-19 pandemic disrupted workflows in the healthcare sector across the world. The outbreak forced several industries to shut down temporarily including sub-domains of healthcare services including single cell mult-iomics.
- However, the rise in chronic diseases and infectious diseases such as Covid-19 increased the demand for single cell multi-omics. Moreover, it could be used to study human immune response to Covid-19 infection.
- Researchers uncovered several evidences of coordinated immune response to Covid-19 progress and various cellular components that could be used in developing targeted therapeutic interventions.
The report segments the global single cell multi-omics market on the basis of type, application, and region.
Based on type, the single cell genomics segment held the largest share in 2020, accounting for more than two-fifths of the market. However, the single cell proteomics segment is expected to manifest the highest CAGR of 19.9% from 2021 to 2030.
On the basis of application, the oncology segment dominated the market in terms of revenue in 2020, contributing to more than one-third of the market. However, the neurology segment is expected to register the highest CAGR of 19.7% during the forecast period.
The global single cell multiomics market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the largest share in 2020, accounting for nearly half of the market. However, the market across Europe is expected to register the highest CAGR of 22.8% during the forecast period.
The global single cell multiomics market includes an in-depth analysis of the prime market players such as BGI Genomics Co. Ltd., Bio-Rad Laboratories (Celsee, Inc.), Fluidigm Corporation, Cytiva Life Science (Previously GE), 10x Genomics, Illumina, Inc., MissionBio, NanoString Technologies, QIAGEN N.V., and Takara Bio.
Trending Reports of Healthcare:
Veterinary Imaging Market - Global Opportunity Analysis and Industry Forecast, 2019-2028
Immunoassay Market - Global Opportunity Analysis and Industry Forecast, 2019-2028
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch (dot) com